NASDAQ:ESTAEstablishment Labs Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Establishment Labs Holdings Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $17.70 +0.20 (+1.14 %) (As of 08/5/2020 04:00 PM ET) Add Compare Share Today's Range$17.00Now: $17.70▼$17.7150-Day Range$15.17MA: $17.15▼$18.6852-Week Range$7.56Now: $17.70▼$29.78Volume104,395 shsAverage Volume106,875 shsMarket Capitalization$412.92 millionP/E RatioN/ADividend YieldN/ABeta1.39 ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsInsider TradesInstitutional OwnershipHeadlinesSocial Media Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic plastic surgery and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Divina 3D simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and distributes Puregraft line of products that is used to remove blood, lipids, and other components from adipose tissue. The company sells its products through exclusive distributors and direct sales force in 60 countries worldwide. Establishment Labs Holdings Inc. was founded in 2004 and is headquartered in Alajuela, Costa Rica.Read More Beat the Market (BTM) Rank™ 3.3 Analyst's Opinion Consensus RatingEstablishment Labs has received a consensus rating of Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $26.00, Establishment Labs has a potential upside of 48.6% from its current price of $17.50.Amount of Analyst CoverageEstablishment Labs has only been the subject of 2 research reports in the past 90 days. Previous Next 2.4 Community Rank Outperform VotesEstablishment Labs has received 83 “outperform” votes. (Add your “outperform” vote.)Underperform VotesEstablishment Labs has received 87 “underperform” votes. (Add your “underperform” vote.)Community SentimentEstablishment Labs has received 51.18% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Establishment Labs and other stocks. Vote “Outperform” if you believe ESTA will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ESTA will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldEstablishment Labs does not currently pay a dividend.Dividend GrowthEstablishment Labs does not have a long track record of dividend growth. Previous Next 4.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Establishment Labs insiders have bought more of their company's stock than they have sold. Specifically, they have bought $171.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 2.64% of the stock of Establishment Labs is held by insiders.Percentage Held by Institutions53.33% of the stock of Establishment Labs is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Establishment Labs are expected to grow in the coming year, from ($1.65) to ($1.03) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Establishment Labs is -8.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Establishment Labs is -8.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEstablishment Labs has a P/B Ratio of 9.11. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.3Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 4.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™2.07 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical appliances & supplies Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:ESTA Previous Symbol CUSIPN/A CIKN/A Webwww.establishmentlabs.com Phone506 2434 2400Debt Debt-to-Equity Ratio0.54 Current Ratio6.58 Quick Ratio5.45Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$89.57 million Price / Sales4.61 Cash FlowN/A Price / Cash FlowN/A Book Value$1.92 per share Price / Book9.22Profitability EPS (Most Recent Fiscal Year)($1.86) Net Income$-38,150,000.00 Net Margins-48.39% Return on Equity-75.95% Return on Assets-34.02%Miscellaneous Employees505 Outstanding Shares23,329,000Market Cap$412.92 million Next Earnings Date8/6/2020 (Confirmed) OptionableNot Optionable $17.70 +0.20 (+1.14 %) (As of 08/5/2020 04:00 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive ESTA News and Ratings via Email Sign-up to receive the latest news and ratings for ESTA and its competitors with MarketBeat's FREE daily newsletter. Establishment Labs (NASDAQ:ESTA) Frequently Asked Questions How has Establishment Labs' stock been impacted by COVID-19 (Coronavirus)? Establishment Labs' stock was trading at $15.15 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ESTA shares have increased by 16.8% and is now trading at $17.70. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Establishment Labs? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Establishment Labs in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Establishment Labs. When is Establishment Labs' next earnings date? Establishment Labs is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Establishment Labs. How can I listen to Establishment Labs' earnings call? Establishment Labs will be holding an earnings conference call on Thursday, August 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available. How were Establishment Labs' earnings last quarter? Establishment Labs Holdings Inc (NASDAQ:ESTA) issued its quarterly earnings results on Thursday, May, 7th. The company reported ($0.79) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.30) by $0.49. The firm earned $24.48 million during the quarter, compared to the consensus estimate of $23.10 million. Establishment Labs had a negative net margin of 48.39% and a negative return on equity of 75.95%. View Establishment Labs' earnings history. What price target have analysts set for ESTA? 3 equities research analysts have issued 1 year price targets for Establishment Labs' shares. Their forecasts range from $20.00 to $35.00. On average, they expect Establishment Labs' share price to reach $26.00 in the next twelve months. This suggests a possible upside of 46.9% from the stock's current price. View analysts' price targets for Establishment Labs. Has Establishment Labs been receiving favorable news coverage? Press coverage about ESTA stock has trended somewhat negative on Wednesday, according to InfoTrie Sentiment. The research group rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Establishment Labs earned a coverage optimism score of -1.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 5.0 out of 10, indicating that recent press coverage is somewhat likely to have an impact on the company's share price in the next several days. View the latest news about Establishment Labs. Who are some of Establishment Labs' key competitors? Some companies that are related to Establishment Labs include Avanos Medical (AVNS), Inogen (INGN), Invacare (IVC), RTI Surgical (RTIX), Lakeland Industries (LAKE), Sientra (SIEN), ConforMIS (CFMS), COLLPLANT HOLDI/S (CLGN), Histogenics (HSGX), Allied Healthcare Products (AHPI), Ocugen (OCGN), Rewalk Robotics (RWLK), Precision Therapeutics (POAI), NanoVibronix (NAOV) and Bionik Laboratories (BNKL). View all competitors. What other stocks do shareholders of Establishment Labs own? Based on aggregate information from My MarketBeat watchlists, some companies that other Establishment Labs investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Sientra (SIEN), Allergan (AGN), BCE (BCE), Canadian Imperial Bank of Commerce (CM), Conduent (CNDT), Canadian Natural Resources (CNQ), Chevron (CVX) and Evolus (EOLS). Who are Establishment Labs' key executives? Establishment Labs' management team includes the following people: Mr. Juan Jose Chacon Quiros, Founder, CEO & Exec. Director (Age 47)Mr. Salvador Santos Dada, Chief Operating Officer (Age 37)Mr. Eddie De Oliveira, VP of Sales, Brazil (Age 36)Ms. Renee M. Gaeta, Chief Financial Officer (Age 38)Mr. Roberto De Mezerville, Chief Technology Officer (Age 39) When did Establishment Labs IPO? (ESTA) raised $50 million in an IPO on Thursday, July 19th 2018. The company issued 3,100,000 shares at a price of $15.00-$17.00 per share. Jefferies and Cowen served as the underwriters for the IPO and BTIG was co-manager. What is Establishment Labs' stock symbol? Establishment Labs trades on the NASDAQ under the ticker symbol "ESTA." Who are Establishment Labs' major shareholders? Establishment Labs' stock is owned by many different retail and institutional investors. Top institutional shareholders include BigSur Wealth Management LLC (0.63%), CWM LLC (0.53%), Cambridge Investment Research Advisors Inc. (0.07%) and MV Capital Management Inc. (0.02%). Company insiders that own Establishment Labs stock include David L Bonvenuto, Jw Asset Management, Llc, Mezerville Roberto De and Nicholas Sheridan Lewin. View institutional ownership trends for Establishment Labs. Which institutional investors are selling Establishment Labs stock? ESTA stock was sold by a variety of institutional investors in the last quarter, including BigSur Wealth Management LLC, and MV Capital Management Inc.. View insider buying and selling activity for Establishment Labs. Which institutional investors are buying Establishment Labs stock? ESTA stock was purchased by a variety of institutional investors in the last quarter, including CWM LLC, and Cambridge Investment Research Advisors Inc.. Company insiders that have bought Establishment Labs stock in the last two years include David L Bonvenuto, Jw Asset Management, Llc, Mezerville Roberto De, and Nicholas Sheridan Lewin. View insider buying and selling activity for Establishment Labs. How do I buy shares of Establishment Labs? Shares of ESTA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Establishment Labs' stock price today? One share of ESTA stock can currently be purchased for approximately $17.70. How big of a company is Establishment Labs? Establishment Labs has a market capitalization of $412.92 million and generates $89.57 million in revenue each year. The company earns $-38,150,000.00 in net income (profit) each year or ($1.86) on an earnings per share basis. Establishment Labs employs 505 workers across the globe. What is Establishment Labs' official website? The official website for Establishment Labs is www.establishmentlabs.com. How can I contact Establishment Labs? Establishment Labs' mailing address is Building B15 and 25 Coyol Free Zone, Alajuela G2, . The company can be reached via phone at 506 2434 2400 or via email at [email protected] This page was last updated on 8/5/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
